Clinical Trial NCT06050226
Trial
Wuhan createrna science – MY008211A- PNH-2-01 (NCT06050226)
Clinical trial ID
NCT06050226
Drug name
MY008211A
Company:
Wuhan createrna science
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
---
Current status
Recruiting
Start
07/2023
Substance
---
Research question
Efficacy of MY008211A in patients with signs of acute hemolysis
Delivery method of drug
Oral
Frequency
2 x daily
Clinical trial locations
China